You have 9 free searches left this month | for more free features.

PML

Showing 1 - 25 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Progressive Multifocal Leukoencephalopathy (PML)

Recruiting
  • Progressive Multifocal Leukoencephalopathy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Progressive Multifocal Leukoencephalopathy Trial (CE-VST01-JC)

    Not yet recruiting
    • Progressive Multifocal Leukoencephalopathy
    • CE-VST01-JC
    • (no location specified)
    Sep 14, 2022

    Evaluate PML Risk Host Markers for PML Risk Host Markers for PML

    Completed
    • Multiple Sclerosis
      • Salt Lake City, Utah
        Rocky Mountain MS Research Group
      Feb 17, 2021

      Multiple Sclerosis (MS) Registries

      Active, not recruiting
      • Progressive Multifocal Leukoencephalopathy
      • Tysabri
      • Cambridge, Massachusetts
        Research Site
      Mar 21, 2022

      HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Filgrastim, Cytarabine, Zidovudine)

      Completed
      • HIV Infections
      • Leukoencephalopathy, Progressive Multifocal
      • Aurora, Colorado
      • +8 more
      Oct 28, 2021

      HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Cidofovir, Probenecid)

      Completed
      • HIV Infections
      • Leukoencephalopathy, Progressive Multifocal
      • Birmingham, Alabama
      • +18 more
      Oct 27, 2021

      Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma Trial in Roma (CD19-CAR_Lenti T cell)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • CD19-CAR_Lenti T cell
      • Roma, Italy
        IRCCS Ospedale Pediatrico Bambino Gesù
      Mar 24, 2021

      DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

      Completed
      • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
      • +8 more
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Jul 12, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +15 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Chicago, Illinois
      • +2 more
      Jan 12, 2023

      Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

      Completed
      • Progressive Multifocal Leukoencephalopathy
      • PyVST
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

      Not yet recruiting
      • Multiple Sclerosis
      • Progressive Multifocal Leukoencephalopathy
      • 89 Zr-Df-crefmirlimab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      May 13, 2023

      Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

      Recruiting
      • Progressive Multifocal Leukoencephalopathy
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 2, 2022

      Progressive Multifocal Leukoencephalopathy Trial in France (Collection of blood and urine, Spinal tap, Brain MRI)

      Recruiting
      • Progressive Multifocal Leukoencephalopathy
      • Collection of blood and urine
      • +3 more
      • Bordeaux, France
      • +3 more
      Mar 15, 2022

      Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Brussels, Belgium
      • +30 more
      Aug 9, 2022

      APL Trial in Shanghai (Chidamide+venetoclax)

      Active, not recruiting
      • APL
      • Shanghai, Shanghai, China
        Jiong HU
      May 30, 2023

      Diabetes, Type 2, Hypertension Trial in Singapore (Bilingual prescription medication labels)

      Withdrawn
      • Diabetes Mellitus, Type 2
      • Hypertension
      • Bilingual prescription medication labels
      • Singapore, Singapore
        Singapore General Hospital
      May 17, 2022

      Progressive Multifocal Leukoencephalopathy, AIDS Trial in Hangzhou (Pembrolizumab)

      Unknown status
      • Progressive Multifocal Leukoencephalopathy
      • AIDS
      • Hangzhou, Zhejiang, China
        the first affiliated hospital of Zhejiang university school of m
      Sep 18, 2019

      Lung Cancer Trial in Aurora (Bronchoscopies, Sputum Sample, Venipuncture)

      Recruiting
      • Lung Cancer
      • Bronchoscopies
      • +2 more
      • Aurora, Colorado
      • +1 more
      Oct 18, 2021

      Multiple Sclerosis Trial in Czechia (Natalizumab)

      Recruiting
      • Multiple Sclerosis
      • Brno, Czechia
      • +14 more
      Feb 2, 2022

      Natalizumab Extended Interval Dosing in a French Cohort

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • Natalizumab Injection [Tysabri]
      • Bobigny, France
      • +4 more
      Mar 8, 2022

      Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

      Recruiting
      • Acute Promyelocytic Leukemia
      • +2 more
      • Beijing, Beijing, China
        Peking University Institute of Hematology
      Apr 26, 2023

      Iatrogenic Hypocalcemia Trial in Hospitalet de Llobregat, L'Hospitalet De Llobregat (ICG angiography to show vascular map of

      Recruiting
      • Iatrogenic Hypocalcemia
      • ICG angiography to show vascular map of parathyroid glands
      • Hospitalet de Llobregat, Barcelona, Spain
      • +1 more
      Jan 19, 2023

      Inflammation in Progressive Multifocal Leukoencephalopathy (PML)

      Completed
      • Progressive Multifocal Leukoencephalopathy
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Feb 26, 2019

        Do CCR5 Antagonists Improve Overall Survival of AIDS-related

        Completed
        • AIDS
        • Progressive Multifocal Leucoencephalopathy (PML)
        • Measure of overall survival
        • (no location specified)
        May 29, 2019

        Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

        Active, not recruiting
        • Acute Myeloid Leukemia With FLT3/ITD Mutation
        • +5 more
        • Biopsy
        • +7 more
        • Lewes, Delaware
        • +42 more
        Mar 15, 2022